G
Gathari Ndirangu
Researcher at Kenyatta National Hospital
Publications - 4
Citations - 74
Gathari Ndirangu is an academic researcher from Kenyatta National Hospital. The author has contributed to research in topics: HPV vaccines & Cervical cancer. The author has an hindex of 3, co-authored 3 publications receiving 69 citations.
Papers
More filters
Journal ArticleDOI
Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa.
Hugo De Vuyst,Gathari Ndirangu,Manivasan Moodley,Vanessa Tenet,Benson B. Estambale,Chris J.L.M. Meijer,Peter J.F. Snijders,Gary M. Clifford,Silvia Franceschi +8 more
TL;DR: The data suggest that current prophylactic HPV vaccines against HPV16 and 18 may prevent similar proportions of cervical SCC in HIV‐positive as in HIV-negative women provided that vaccine‐related protection is sustained after HIV infection.
Journal Article
The Impact of Human Immunodeficiency Virus and Human Papillomavirus Co-Infection on HPV Genotype Distribution and Cervical Lesion Grade in a Semi-Urban Population in Tigoni, Kenya
Lucy Muchiri,Christine B. Sekkade-Kigondu,Gathari Ndirangu,Peter Gichangi,James Machoki,Benson B. Estambale,Marleen Temmerman +6 more
TL;DR: The identification of HPV’s role in cervical cancer has led to important advances in primary prevention through vaccination and diagnosis through HPV detection, and development of the next generation of HPV vaccines will require inclusion of relevant antigens from several HPV types.
Journal ArticleDOI
Human papillomavirus prevalence in invasive cervical carcinoma by HIV Status
Hugo De Vuyst,Gathari Ndirangu,Manivasan Moodley,Vanessa Tenet,Benson B. Estambale,Chris J.L.M. Meijer,Peter J.F. Snijders,Gary M. Clifford,Silvia Franceschi +8 more
TL;DR: This study compares the prevalence of HPV types in ICC by HIV status to elucidate the influence of immunity on the carcinogenicity of different HPV types and the potential impact of prophylactic HPV vaccines in populations with high HIV prevalence.
Journal ArticleDOI
What Have We Learned? Implementation of a Shared Learning Agenda and Access Strategy for the Hormonal Intrauterine Device
Kate H Rademacher,Tabitha Sripipatana,Kendal Danna,Deborah Sitrin,Aurélie Brunie,Katie M Williams,Kayode Afolabi,Francia Rasoanirina,Saumya RamaRao,Anne Pfitzer,Devon Blaze Cain,Morgan Simon,Elaine P Menotti,Anna Hazelwood,Anthony Adindu Nwala,Zainab Saidu,Raveena Chowdhury,Anne Taiwo,A Chidanyika,Gathari Ndirangu,Markus J. Steiner,Marie Chantale Lepine,Rick Homan,Abdulmumin Saad,John Vivalo,Laneta Dorflinger +25 more
TL;DR: Early evidence on clients' and providers' experiences with the hormonal intrauterine device in sub-Saharan Africa and lessons learned from implementing a shared learning agenda can inform strategies to expand access in other low and middle-income countries as discussed by the authors .